0333 321 3021
EnglishArabicBengaliBosnianBulgarianCatalanChinese (Simplified)Chinese (Traditional)CroatianCzechDanishDutchEstonianFilipinoFinnishFrenchGermanGreekHindiHungarianIgboItalianJapaneseKoreanKurdish (Kurmanji)LatvianLithuanianLuxembourgishMacedonianMalayMalteseNepaliNorwegianPersianPolishPortuguesePunjabiRomanianRussianSerbianSlovakSlovenianSomaliSpanishSudaneseSwahiliSwedishThaiTurkishUkrainianUrduVietnameseWelshYorubaMonitor is the sector regulator for health services in England. One of its roles is to ensure that Health and Social Care Act 2012 is implemented and a key focus of the Act is on integrated care. The Act imposes duties on Clinical Commissioning Groups (CCGs) to ensure that health services are internally integrated (within NHS provided services) and externally integrated (with health and social services provided by others).
Monitor is the sector regulator for health services in England. One of its roles is to ensure that Health and Social Care Act 2012 is implemented and a key focus of the Act is on integrated care. The Act imposes duties on Clinical Commissioning Groups (CCGs) to ensure that health services are internally integrated (within NHS provided services) and externally integrated (with health and social services provided by others) where they consider that it would:
As you may be aware, earlier this year the City Council launched a competitive tendering process for the contract to provide support to the city's voluntary and community sector for the next three years.
We are delighted to announce that Macc has been awarded this contract.
There will be a fund of £550k from the three Manchester Clinical Commissioning Groups (CCGs) available early January 2014, to Manchester’s Voluntary and Community Sector (VCS). The main aim of the programme of work will be to reduce social isolation and loneliness for people over 50 years old in Manchester.
The programme will also aim to build greater understanding of how the Manchester CCGs can work with VCS organisations to improve health and wellbeing outcomes for Manchester residents over the age of 50 years.
The government has commissioned six centres (the What Works Network, https://www.gov.uk/what-works-network) to summarise and share research with local decision-makers including commissioners, head teachers, police and crime commissioners.
During the reorganisation of the NHS the responsibility for production of the Pharmaceutical Needs Assessments (PNAs) transferred to the Health and Wellbeing Boards (HWB) which are hosted by the local authorities.
Manchester HWB and local authority have produced their first draft of the PNA in collaboration with the Greater Manchester Commissioning Support Unit (CSU).
As part of the legislation the draft PNA must be available for local health partners to comment on the contents of the assessment before it is finalised and published.
There will be a fund of £550k from the three Manchester Clinical Commissioning Groups (CCGs) available soon to Manchester’s VCS. The main aim of the programme of work will be to reduce social isolation and loneliness for people over 50yrs old in Manchester.
The programme will also aim to build greater understanding of how the Manchester CCGs can work with VCS organisations to improve health and wellbeing outcomes for Manchester residents over the age of 50yrs.
Manchester City Council is shortly intending to put out to competitive tender the following services:
1. Advocacy Services
2. Carer Support Services
3. Employment Support Services
4. Dementia Support Services
The Joint Strategic Needs Assessment (JSNA) analyses the health needs of populations to inform and guide commissioning of health, well-being and social care services within local authority areas.
This agreement provides a framework governing the respective roles of the Manchester Health and Wellbeing Board and the Voluntary and Community Sector (VCS) in helping to produce and further develop the Joint Strategic Needs Assessment (JSNA) for Manchester.
The GlaxoSmithKline IMPACT Awards are an annual scheme, funded by GlaxoSmithKline as part of the company’s commitment to promote community health and well-being. The awards have been running since 1997, and are organised and managed in partnership with The King’s Fund, a leading independent health charity working to improve health and social care.
The GlaxoSmithKline IMPACT Awards recognise and reward small to medium sized charities that are doing excellent work to improve people’s health.
Printer-friendly version